Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Carotid revascularization · Pennsylvania | Carotid revascularization · New York | |
|---|---|---|
| Surgeons, 2024 | 23 | 32 |
| Medicare fee-for-service cases | 1,666 | 1,508 |
| Growth since 2019 (Medicare FFS) | −3.1%/yr | −6.4%/yr |
| Forecast cases (Medicare FFS) | 1,760 in 2030 | 1,510 in 2030 |
| Forecast growth | +0.9%/yr to 2030 | 0%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.2 | 0.8 |
| Medicare Advantage share | 58% | 57% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 72 | 47 |
| Top 10 surgeons' share | 59% | 50% |
| Surgeons growing | 0 | 2 |
| New since the base year | 5 | 2 |
| Likely to stop billing it | 11 by 2026 | 9 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $5,363 | $6,499 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.